Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 23.79
+1.76 (7.99%)
At close: Sep 23, 2026
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.62 billion as of September 23, 2026. Its market cap has decreased by -11.46% in one year.
Market Cap
2.62B
Enterprise Value
1.91B
Revenue
219.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.79
ChartMarket Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.62B, a decrease of -35.64%. That is a compound annual growth rate of -10.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 2.62B | -0.17% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hubei Goto Biopharm Group | 2.74B |
| Yantai Zhenghai Biotechnology | 2.69B |
| Guangdong VTR Bio-Tech | 2.66B |
| Shanghai Universal Biotech | 2.64B |
| Shenzhen Bioeasy Biotechnology | 2.60B |
| Shandong Sito Bio-technology | 2.48B |
| Jilin Jian Yisheng Pharmaceutical | 2.30B |
| Suzhou Fushilai Pharmaceutical | 2.19B |